Available online http://arthritis-research.com/content/3/2/077 Introduction A landmark investigation into the genetic basis of murine progressive ankylosis has clarified the physiologic role of extracellular inorganic pyrophosphate (ePPi) in suppressing pathologic deposition of basic calcium phosphate (BCP) (an inclusive term for hydroxyapatite, octacalcium phosphate, and tricalcium phosphate) in articular tissue [1]. A cell membrane protein, ANK, affects ePPi concentrations and the balance of mineralization in articular tissues.
Excess ePPi promotes pathologic mineralization with CPPD crystalsExcess accumulation of ePPi has long been recognized as an important factor in the mineralization of cartilage with calcium pyrophosphate dihydrate (CPPD) crystals. Elevated levels of ePPi are routinely noted in synovial fluids of patients with CPPD deposition disease [2,3]. Chondrocytes are the likely source of the ePPi that participates in the formation of these crystals [4,5]. The elaboration of ePPi by chondrocytes is a bioregulable process, enhanced by transforming growth factor β, ascorbate, retinoic acid, bone morphogenetic protein, transglutaminase, and thyroid hormones and diminished by parathyroid-hormone-related peptide isoforms, insulin-like growth factor-1, tumor necrosis factor α, and interleukin 1. Porcine chondrocytes from aged donors make more ePPi than do chondrocytes from young donors [6]. Signaling mechanisms involved in the regulation of ePPi formation are poorly understood, but adenylyl cyclase activation decreases and protein kinase C activation increases the accumulation of ePPi in media surrounding cartilage or chondrocyte cultures [7]. In addition to causing CPPD crystal formation, excess ePPi accumulation may also affect BCP mineralization.CPPD crystal deposits and elevated ePPi levels are particularly prominent in adult hypophosphatasia, congenital deficiency of tissue-nonspecific alkaline phosphatase. In hypophosphatasia, the predominant phenotypic disease expressions are rickets and osteomalacia. Murine models of hypophosphatasia indicate that the nucleation and initial growth of BCP crystals within matrix vesicles of mineralizing
CommentaryThe ank gene story
AbstractThe underlying molecular defect resulting in the abnormal calcification observed in ank/ank mice has been identified. The responsible nonsense mutation affects the protein product of ank, resulting in diminished production of extracellular inorganic pyrophosphate, an important inhibitor of nucleation and of the growth of apatite crystals. The ank gene product is one of several cell membrane proteins, including ectonucleoside triphosphate pyrophosphohydrolase enzymes and alkaline phosphatase, that regulate extracellular inorganic pyrophosphate levels and thereby regulate mineralization.